Targeted Clinical Trials to Reduce the Risk of Antimicrobial Resistance
$1,984,538N01FY2010AINIH
Ordway Research Institute, Inc., Albany NY
Investigators
Abstract
To evaluate strategies that test the safety and effectiveness of therapeutic approaches/regimens to reduce the probability of the emergence of antibiotic drug resistance by minimizing unnecessary drug exposure.
View original record on NIH RePORTER →